Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Post-transplant lymphoproliferative disease (PTLD): Pharmacological, virological and other determinants.

Pharmacological research - 1 Jan 2011

Stojanova Jana, Caillard Sophie, Rousseau Annick, Marquet Pierre

Abstract excerpt

Post-transplant lymphoproliferative disorders (PTLDs) represent a serious complication in solid organ transplantation and are the first cause of cancer related mortality in this population. Pre-transplant Epstein Barr Virus seronegativity and receipt of T cell depleting agents for induction or se...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytokines
Share to Epstein-Barr Virus Infections
Share to Histocompatibility

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HLA Antigens

Share to Immunosuppressive Agents

Share to Lymphoproliferative Disorders

Share to Organ Transplantation

Share to Risk Assessment

Source

Identifiers

PMID: 21056103
DOI: 10.1016/j.phrs.2010.10.016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-21056103-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Post-transplant lymphoproliferative disease (PTLD): Pharmacological, virological and other determinants.PMID 21056103Read ↗

Posttransplant Lymphoproliferative Disorder Following Kidney Transplantation: A Review.Semantic proximity Read ↗

Infectious Complications and Mortality in Post-Transplant Lymphoproliferative Disorder Following Solid Organ Transplantation: Experiences of 10 Years in a Single CenterSemantic proximity Read ↗

Posttransplant Lymphoproliferative DisordersSemantic proximity Read ↗

Association of HLA alleles and mismatches with post-transplant lymphoproliferative disorder in solid organ transplant recipients: a systematic review and meta-analysis.Semantic proximity Read ↗

Clinical and pathological features of post-transplant lymphoproliferative disorders (PTLD).Semantic proximity Read ↗

Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantationSemantic proximity Read ↗

Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation.Semantic proximity Read ↗

Post-transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease.Semantic proximity Read ↗

Epstein-Barr virus-associated posttransplant lymphoproliferative disorders: new insights in pathogenesis, classification and treatmentSemantic proximity Read ↗

Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far?Semantic proximity Read ↗

Association of HLA Polymorphisms with Post-transplant Lymphoproliferative Disorder in Solid-Organ Transplant RecipientsSemantic proximity Read ↗

EPSTEIN-BARR VIRUS-NEGATIVE LYMPHOPROLIFERATIVE DISORDERS IN LONG-TERM SURVIVORS AFTER HEART, KIDNEY, AND LIVER TRANSPLANT1Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.